Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease

BACKGROUND: Patients with relapsing–remitting multiple sclerosis (RRMS) may experience breakthrough disease despite effective interferon beta (IFNβ) therapy. Fludarabine (FLU) is a chemotherapeutic agent used in lymphoproliferative disorders that may be synergistic when combined with immunomodulator...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ther Adv Neurol Disord
Main Authors: Greenberg, Steven J., Zivadinov, Robert, Lee-Kwen, Peterkin, Sharma, Jitendra, Planter, Margaret, Umhauer, Margaret, Glenister, Norman, Bakshi, Rohit
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2016
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4784253/
https://ncbi.nlm.nih.gov/pubmed/27006698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285615626049
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker